Abiri Arash, Hong Ellen M, Dilley Katelyn K, Nguyen Theodore V, Salmon Mandy K, Grose Elysia M, Tripathi Siddhant H, Venkatesh Sanjena, Kim Yohan, Lee Daniel J, Douglas Jennifer E, Eide Jacob G, Kshirsagar Rijul S, Phillips Katie M, Sedaghat Ahmad R, Lee John M, Tong Charles C L, Adappa Nithin D, Palmer James N, Kuan Edward C
Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, California, U.S.A.
Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.
Laryngoscope. 2025 Feb;135(2):579-585. doi: 10.1002/lary.31725. Epub 2024 Aug 24.
There is growing interest in assessing patient quality of life (QOL) following treatment of sinonasal tumors, including inverted papilloma (IP). We aimed to elucidate the natural history of postoperative QOL outcomes in IP patients treated with surgery.
Cases of sinonasal IP treated surgically at 4 tertiary academic rhinology centers were retrospectively reviewed. SNOT-22 scores were used to evaluate QOL preoperatively and postoperatively (1, 3, 6, 12 months). Repeated-measures ANOVA assessed for differences in mean scores over time. Linear regression identified factors associated with QOL longitudinally.
373 patients were analyzed. Mean preoperative SNOT-22 score was 20.6 ± 20.4, which decreased to 16.3 ± 18.8 (p = 0.041) and 11.8 ± 15.0 (p < 0.001) at 1 and 3 months postoperatively, respectively. No further changes in SNOT-22 scores occurred beyond 3 months postoperatively (p > 0.05). When analyzed by SNOT-22 subdomains, nasal, sleep, and otologic/facial subdomain scores (all p < 0.05) demonstrated improvement at 12-month follow-up compared with preoperative scores; this was not observed for the emotional subdomain score (p = 0.800). Recurrent cases were associated with higher long-term SNOT-22 scores (β = 7.08; p = 0.017). Age, sex, degree of dysplasia, prior surgery, primary site, and smoking history did not correlate with symptoms (all p > 0.05).
QOL outcomes related to IP resection are largely driven by nasal, sleep, and otologic/facial subdomains, though patients appear to experience enduring improvement as early as 3 months postoperatively. Recurrent disease is a major driver of negative QOL.
4 Laryngoscope, 135:579-585, 2025.
评估鼻窦肿瘤(包括内翻性乳头状瘤(IP))治疗后患者的生活质量(QOL),这一兴趣正在日益增长。我们旨在阐明接受手术治疗的IP患者术后QOL结果的自然病程。
回顾性分析4家三级学术鼻科中心接受手术治疗的鼻窦IP病例。使用SNOT-22评分在术前及术后(1、3、6、12个月)评估QOL。重复测量方差分析评估平均评分随时间的差异。线性回归纵向确定与QOL相关的因素。
分析了373例患者。术前SNOT-22平均评分为20.6±20.4,术后1个月和3个月分别降至16.3±18.8(p = 0.041)和11.8±15.0(p < 0.001)。术后3个月后SNOT-22评分未发生进一步变化(p > 0.05)。按SNOT-22子域分析时,与术前评分相比,在12个月随访时,鼻部、睡眠及耳科/面部子域评分(均p < 0.05)显示改善;情感子域评分未观察到这种情况(p = 0.800)。复发病例与较高的长期SNOT-22评分相关(β = 7.08;p = 0.017)。年龄、性别、发育异常程度、既往手术、原发部位及吸烟史与症状均无相关性(均p > 0.05)。
与IP切除相关的QOL结果很大程度上由鼻部、睡眠及耳科/面部子域驱动,不过患者似乎在术后3个月就开始持续改善。复发性疾病是QOL负面的主要驱动因素。
4《喉镜》,135:579 - 585,2025年。